Cannabismarketcap

Compare BioHarvest Sciences (BHST) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

BioHarvest Sciences (BHST)

Price

$1.67

Change

-4.58%

Market Cap

$37.7M

Sector

Biotech

Biotech Sector Peers

All Biotech cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
JAZZJazz Pharmaceuticals$213.25+1.72%$13.73B
INNPFInnocanPharma$1.400.00%$98.0M
XXII22nd Century Group$0.60-7.15%$431.3K

Top Matchups by Market Cap

Companies closest to BioHarvest Sciences in market capitalization — the most meaningful head-to-head comparisons.

PLNHMSO

Planet 13 Holdings

MCap: $36.0M

$0.11-4.37%
Compare
MAPSAncillary

WM Technology (Weedmaps)

MCap: $32.4M

$0.30+0.81%
Compare
ITHUFMSO

iAnthus Capital Holdings

MCap: $32.3M

$0.00460.00%
Compare
VEXTFMSO

Vext Science

MCap: $31.5M

$0.170.00%
Compare
VVIVFLP

Vivo Cannabis

MCap: $30.7M

$0.190.00%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the Biotech sector. Compare across different business models and market segments.

SMGAncillary

Scotts Miracle-Gro

MCap: $2.99B

$51.80+4.19%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $2.27B

$8.54-0.18%
Compare
TRLVMSO

Trulieve Cannabis

MCap: $1.94B

$10.06+0.95%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.34-0.37%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.44B

$52.35+1.79%
Compare

Comparing BHST in the Cannabis Market

BioHarvest Sciences (BHST) is a cannabis biotech companytrading at $1.67 per share with a market capitalization of $37.7M. Among its Biotech peers, BHST ranks #3 by market cap, with trailing twelve-month revenue of $34.5M and a gross margin of 59.3%. The stock has moved -4.58% in the current session, trading on the NASDAQ exchange.

When comparing BHST against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (3.8x), revenue growth (+37.00% YoY), and balance sheet strength (cash of $23.0M vs. debt of $149.0K). The comparison tables above allow you to evaluate BioHarvest Sciences relative to 3 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does BHST compare to other Biotech stocks?+
BioHarvest Sciences has a market cap of $37.7M, placing it among 4 companies in the Biotech sector. Its price-to-sales ratio is 3.8x. Its gross margin is 59.3%. Use the table above to compare these metrics against every Biotech peer.
What is BHST's biggest competitor?+
By market capitalization, the closest comparable company is Planet 13 Holdings (PLNH) with a market cap of $36.0M. Click the compare link to view a full head-to-head analysis.
Is BHST overvalued compared to its peers?+
BioHarvest Sciences trades at a P/S ratio of 3.8x. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than BHST?+
BioHarvest Sciences has a gross margin of 59.3%. Of its 0 sector peers with reported margins, 0 report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare BHST to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside Biotech. You can click any company to see a full side-by-side comparison with BHST covering price, valuation, financials, and growth metrics.

All BHST Comparisons

Every available head-to-head comparison for BioHarvest Sciences.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.